Lifestyle Intervention With Smartphone App and isCGM for People at High Risk of Type 2 Diabetes: Randomized Trial

被引:7
|
作者
Kitazawa, Masaru [1 ]
Takeda, Yasunaga [1 ]
Hatta, Mariko [1 ]
Horikawa, Chika [2 ]
Sato, Takaaki [1 ]
Osawa, Taeko [1 ]
Ishizawa, Masahiro [1 ]
Suzuki, Hiroshi [1 ]
Matsubayashi, Yasuhiro [1 ]
Fujihara, Kazuya [1 ]
Yamada, Takaho [1 ]
Sone, Hirohito [1 ,3 ]
机构
[1] Niigata Univ, Dept Hematol Endocrinol & Metab, Fac Med, Niigata 9518510, Japan
[2] Univ Niigata Prefecture, Fac Human Life Studies, Dept Hlth & Nutr, Niigata 9500806, Japan
[3] Niigata Univ, Dept Internal Med, Fac Med, 1-754 Asahimachi, Niigata 9518510, Japan
关键词
continuous blood glucose monitor; prevention; prospective randomized trial; smartphone; educational intervention; DOSE-RESPONSE METAANALYSIS; HEALTH MANAGEMENT CENTER; PHYSICAL-ACTIVITY; GLUCOSE-LEVELS; JAPANESE; INDIVIDUALS; PREVENTION; HBA1C;
D O I
10.1210/clinem/dgad639
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: Although conventional interventions for people at high risk of developing type 2 diabetes are usually conducted face-to-face, such interventions are burdensome for health care providers. We developed a lifestyle intervention program combining lifestyle coaching via a smartphone application augmented by intermittently scanned continuous glucose monitoring without burdening health care providers. Its effectiveness for glycemic control and body weight reduction in people at risk of type 2 diabetes was investigated.Materials and Methods: For this 12-week randomized unblinded trial with offline recruitment, participants with a hemoglobin A1c level of 5.6% to 6.4% or a fasting blood glucose of 110 to 125 mg/dL and body mass index (BMI) >23 kg/m2 but <40 kg/m(2) were randomly assigned to the intervention group (App) and control group (C). The primary endpoint was the difference in time in range of blood glucose between 70 and 140 mg/dL (3.9-7.8 mmol/L) before and after the study period between the 2 groups.Results: Among 168 patients (mean age, 48.1 years; mean BMI, 26.6 kg/m(2); and male, 80.4%), 82 and 86 were assigned to the App group and C group, respectively. After 12 weeks, time in range of blood glucose at 70 to 140 mg/dL significantly improved in the App group compared with the C group (-2.6 minutes/day vs +31.5 minutes/day, P = .03). Changes in time above range did not differ, whereas time below range (blood glucose <70 mg/dL; +23.5 minutes/day vs -8.9 minutes/day, P = .02) improved in the App group. BMI (-0.26 vs -0.59, P = .017) was reduced in the App group compared with the C group.Conclusion: Intervention with a smartphone app and intermittently scanned continuous glucose monitoring increased glycemic control accompanied by decreased carbohydrate intake and weight loss. Further trials are needed to confirm whether these interventions can reduce incident type 2 diabetes.
引用
收藏
页码:1060 / 1070
页数:11
相关论文
共 50 条
  • [1] Effects of the Lifestyle Intervention Program GLICEMIA in People at Risk for Type 2 Diabetes: A Cluster-Randomized Controlled Trial
    Schmiedel, Karin
    Mayr, Andreas
    Fiessler, Cornelia
    Schlager, Helmut
    Friedland, Kristina
    DIABETES CARE, 2015, 38 (05) : 937 - 939
  • [2] A randomized controlled trial of an app-based intervention on physical activity and glycemic control in people with type 2 diabetes
    Kim, Gyuri
    Kim, Seohyun
    Lee, You-Bin
    Jin, Sang-Man
    Hur, Kyu Yeon
    Kim, Jae Hyeon
    BMC MEDICINE, 2024, 22 (01):
  • [3] A yoga intervention for type 2 diabetes risk reduction: a pilot randomized controlled trial
    McDermott, Kelly A.
    Rao, Mohan Raghavendra
    Nagarathna, Raghuram
    Murphy, Elizabeth J.
    Burke, Adam
    Nagendra, Ramarao Hongasandra
    Hecht, Frederick M.
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2014, 14
  • [4] Effects of a culturally adapted lifestyle intervention on cardio-metabolic outcomes: a randomized controlled trial in Iraqi immigrants to Sweden at high risk for Type 2 diabetes
    Siddiqui, Faiza
    Kurbasic, Azra
    Lindblad, Ulf
    Nilsson, Peter M.
    Bennet, Louise
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2017, 66 : 1 - 13
  • [5] The Effects of a Lifestyle Intervention Supported by the InterWalk Smartphone App on Increasing Physical Activity Among Persons With Type 2 Diabetes: Parallel-Group, Randomized Trial
    Thorsen, Ida Kaer
    Yang, Yanxiang
    Valentiner, Laura Staun
    Gluemer, Charlotte
    Karstoft, Kristian
    Brond, Jan Christian
    Nielsen, Rasmus Oestergaard
    Brons, Charlotte
    Christensen, Robin
    Nielsen, Jens Steen
    Vaag, Allan Arthur
    Pedersen, Bente Klarlund
    Langberg, Henning
    Ried-Larsen, Mathias
    JMIR MHEALTH AND UHEALTH, 2022, 10 (09):
  • [6] Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males
    Kosaka, K
    Noda, M
    Kuzuya, T
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2005, 67 (02) : 152 - 162
  • [7] Cardiometabolic Risk Factor Response to a Lifestyle Intervention: A Randomized Trial
    Harrington, Deirdre M.
    Champagne, Catherine M.
    Broyles, Stephanie T.
    Johnson, William D.
    Tudor-Locke, Catrine
    Katzmarzyk, Peter T.
    METABOLIC SYNDROME AND RELATED DISORDERS, 2015, 13 (03) : 125 - 131
  • [8] Effects of Genetic Risk on Incident Type 2 Diabetes and Glycemia: The T2D-GENE Lifestyle Intervention Trial
    Lankinen, Maria Anneli
    Nuotio, Petrus
    Kauppinen, Susanna
    Koivu, Noora
    Tolonen, Ulla
    Malkki-Keinanen, Katriina
    Oravilahti, Anniina
    Kuulasmaa, Teemu
    Uusitupa, Matti
    Schwab, Ursula
    Laakso, Markku
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 110 (01) : 130 - 138
  • [9] Long-term outcomes of lifestyle intervention to prevent type 2 diabetes in people at high risk in primary health care
    Rintamaki, Reeta
    Rautio, Nina
    Peltonen, Markku
    Jokelainen, Jari
    Keinanen-Kiukaanniemi, Sirkka
    Oksa, Heikki
    Saaristo, Timo
    Puolijoki, Hannu
    Saltevo, Juha
    Tuomilehto, Jaakko
    Uusitupa, Matti
    Moilanen, Leena
    PRIMARY CARE DIABETES, 2021, 15 (03) : 444 - 450
  • [10] A lifestyle intervention to reduce Type 2 diabetes risk in Dutch primary care: 2.5-year results of a randomized controlled trial
    Vermunt, P. W. A.
    Milder, I. E. J.
    Wielaard, F.
    de Vries, J. H. M.
    Baan, C. A.
    van Oers, J. A. M.
    Westert, G. P.
    DIABETIC MEDICINE, 2012, 29 (08) : E223 - E231